Literature DB >> 35243588

Evaluation of Relationship Between SOD1 50-bp Deletion Gene Polymorphism, Cu, Zn Level, and Viscosity in Postmenopausal Osteoporosis Patients with Vertebral Fractures.

Ahu Soyocak1, Fulya Doganer2, Dilek Duzgun Ergun3, Metin Budak4, Didem Turgut Coşan5, Merih Ozgen6.   

Abstract

Oxidative stress plays a role in the pathogenesis of bone loss, causing low bone mineral density (BMD) and associated osteoporotic fractures. In our study, we aimed to investigate the relationship of SOD1 50-bp insertion(Ins)/deletion(Del) polymorphism that is involved in oxidative stress metabolism, Cu and Zn element concentrations, and plasma viscosity level, with postmenopausal osteoporosis and related vertebral fractures. The study included 167 voluntary individuals. The 50-bp Ins/Del polymorphism of SOD1 was determined by allele-specific PCR. Plasma Cu and Zn levels were measured by atomic absorption spectrophotometry (AAS). The plasma viscosity was determined using the Harkness Capillary Viscometer device. In our study, the distribution of SOD1 promoter 50-bp Ins/Del polymorphism did not indicate a significant difference between the groups and in postmenopausal osteoporosis patients with and without fractures (p > 0.05). The Ins/Ins genotype was found to be common in individuals in both groups. The Cu and Zn levels of the study group were found to be between the normal reference values (p > 0.05). It was determined that plasma viscosity increased significantly in the group of osteoporotic patients and in patients with postmenopausal osteoporosis with fractures (p < 0.01). In addition, plasma viscosity was found to significantly increase in patients with Ins/Ins genotype and fractures (p < 0.01). Postmenopausal osteoporosis and associated vertebral fracture were found not to be directly related to SOD1 50-bp polymorphism and Cu and Zn element levels. Plasma viscosity levels were found to increase due to the increase in oxidative stress products. Further studies are needed to clarify the roles and relationships of SOD genes and trace elements in the development of postmenopausal osteoporosis and vertebral fracture.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cu; Fracture; Osteoporosis; Plasma viscosity; Polymorphism; SOD1; Zn

Year:  2022        PMID: 35243588     DOI: 10.1007/s12011-022-03185-8

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  37 in total

1.  Association of oxidative stress with postmenopausal osteoporosis and the effects of hydrogen peroxide on osteoclast formation in human bone marrow cell cultures.

Authors:  Ki Hyun Baek; Ki Won Oh; Won Young Lee; Seong Su Lee; Mee Kyoung Kim; Hyuk Sang Kwon; Eun Jung Rhee; Je Ho Han; Ki Ho Song; Bong Yun Cha; Kwang Woo Lee; Moo Il Kang
Journal:  Calcif Tissue Int       Date:  2010-07-08       Impact factor: 4.333

Review 2.  Osteoporosis: a complex disorder of aging with multiple genetic and environmental determinants.

Authors:  Serge L Ferrari
Journal:  World Rev Nutr Diet       Date:  2005       Impact factor: 0.575

3.  Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease.

Authors:  J A Kanis; P Delmas; P Burckhardt; C Cooper; D Torgerson
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

4.  Association between oxidative stress and bone mineral density.

Authors:  S Basu; K Michaëlsson; H Olofsson; S Johansson; H Melhus
Journal:  Biochem Biophys Res Commun       Date:  2001-10-19       Impact factor: 3.575

Review 5.  An overview and management of osteoporosis.

Authors:  Tümay Sözen; Lale Özışık; Nursel Çalık Başaran
Journal:  Eur J Rheumatol       Date:  2016-12-30

Review 6.  Superoxide dismutases: role in redox signaling, vascular function, and diseases.

Authors:  Tohru Fukai; Masuko Ushio-Fukai
Journal:  Antioxid Redox Signal       Date:  2011-06-06       Impact factor: 8.401

7.  A crucial role for thiol antioxidants in estrogen-deficiency bone loss.

Authors:  Jenny M Lean; Julie T Davies; Karen Fuller; Christopher J Jagger; Barrie Kirstein; Geoffrey A Partington; Zoë L Urry; Timothy J Chambers
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

8.  Superoxide Dismutase 2 Polymorphisms and Osteoporosis in Asian Indians: A Genetic Association Analysis.

Authors:  Chaitali Botre; Arjun Shahu; Neeraj Adkar; Yogesh Shouche; Saroj Ghaskadbi; Richa Ashma
Journal:  Cell Mol Biol Lett       Date:  2015-12       Impact factor: 5.787

Review 9.  A comprehensive overview on osteoporosis and its risk factors.

Authors:  Farkhondeh Pouresmaeili; Behnam Kamalidehghan; Maryam Kamarehei; Yong Meng Goh
Journal:  Ther Clin Risk Manag       Date:  2018-11-06       Impact factor: 2.423

Review 10.  Pathophysiology and treatment of osteoporosis: challenges for clinical practice in older people.

Authors:  J Barnsley; G Buckland; P E Chan; A Ong; A S Ramos; M Baxter; F Laskou; E M Dennison; C Cooper; Harnish P Patel
Journal:  Aging Clin Exp Res       Date:  2021-03-20       Impact factor: 3.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.